Literature DB >> 4183778

The mechanism of action of anti-lymphocyte serum. Studies of antibody eluate.

E M Lance.   

Abstract

Studies designed to gain insight into the mechanism of action of the active component of antilymphocyte serum were carried out using an antibody eluate prepared from the IgG fraction of anti-lymphocyte serum by absorption and subsequent elution from thymocyte membrane. The resulting antibody eluate was labeled with radionuclide tracer to determine the fate of the antibody in vivo. The result indicated that anti-lymphocytic antibodies are eliminated from recipients extremely rapidly. The mechanism for this rapid clearance appears to depend upon the absorption of antibody molecules onto lymphocyte surfaces and the subsequent clearing and degradation of the antibody-lymphocyte complexes by the reticuloendothelial system. Distribution studies confirm that the major site of antibody-lymphocyte interaction occurs in the periphery with relatively little penetration of antibody within lymphoid organs. Radioautographic studies showed that the pattern of localization within lymphoid and other organs is confined to rather specific areas. These observations are believed to offer strong support for the notion that anti-lymphocyte serum achieves its immunosuppressive effect by bringing about a selective ablation of the population of recirculating lymphocytes.

Mesh:

Substances:

Year:  1969        PMID: 4183778      PMCID: PMC2138667          DOI: 10.1084/jem.130.1.49

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Passive transfer of bone marrow homotransplantation immunity with specific antisera.

Authors:  R M GARVER; L J COLE
Journal:  J Immunol       Date:  1961-03       Impact factor: 5.422

2.  The zone of localization of antibodies VIII. Some properties of the antigen responsible for the renal localization of anti-kidney serum.

Authors:  H N EISEN; D PRESSMAN
Journal:  J Immunol       Date:  1950-06       Impact factor: 5.422

3.  Central and peripheral effects of anti-lymphocyte sera.

Authors:  J L Turk; D A Willoughby
Journal:  Lancet       Date:  1967-02-04       Impact factor: 79.321

4.  Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice.

Authors:  A M Denman; E P Frenkel
Journal:  Immunology       Date:  1968-01       Impact factor: 7.397

5.  The effects of heterologous antilymphocytic antiserum in the late prenatal and early postnatal period in mice.

Authors:  S V Jooste
Journal:  Transplantation       Date:  1968-03       Impact factor: 4.939

6.  Further experiments on the action of antilymphocytic antiserum.

Authors:  R H Levey; P B Medawar
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

7.  Elimination of normal horse IgG labelled with Iodine-131 in rats receiving horse anti-rat lymphocytic IgG.

Authors:  J G Clark; K James; M F Woodruff
Journal:  Nature       Date:  1967-08-19       Impact factor: 49.962

8.  Experimental allergic glomerulonephritis induced in the rabbit with heterologous renal antigens.

Authors:  E R Unanue; F J Dixon
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

9.  Histopathological effects in mice of heterologous antilymphocyte serum.

Authors:  R N Taub; E M Lance
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

10.  The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type.

Authors:  B H WAKSMAN; S ARBOUYS; B G ARNASON
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

View more
  11 in total

1.  Inhibition of T-cell differentiation by an antibody to a soluble thymic factor.

Authors:  E F Potworowski; D Lefebvre; G Lussier; J A Teodorczyk
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

2.  Antilymphocyte antibody purified by immunoabsorption and elution.

Authors:  S Yamana; R S Read; D J Davies; R C Nairn
Journal:  Clin Exp Immunol       Date:  1974-03       Impact factor: 4.330

Review 3.  The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives.

Authors:  E M Lance
Journal:  Clin Exp Immunol       Date:  1970-06       Impact factor: 4.330

4.  Age-decrease of cells sensitive to an autoantibody-specific for thymocytes and thymus-dependent lymphocytes in NZB mice.

Authors:  T Shirai; T Yoshiki; R C Mellors
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

5.  Analysis of the biological activity of antilymphocyte serum. 3. Concentration of immunosuppressive activity in one IgG subfraction and its inhibition by another.

Authors:  R J Perper; R E Monovich; T J Van Gorder
Journal:  Immunology       Date:  1971-12       Impact factor: 7.397

6.  The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat.

Authors:  C G Winearls; J W Fabre; P R Millard; P J Morris
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

7.  Depletion of lymphoid tissues by tilorone. Ultrastructure and synergistic interaction with antilymphocyte serum.

Authors:  S Levine; P Cacho; R Sowinski; W L Thelmo
Journal:  Am J Pathol       Date:  1983-05       Impact factor: 4.307

8.  Increased Incidence of Lymphoma in C3H/HeJ Adult Mice Injected with Gross Virus and Antithymocytic Serum.

Authors:  D L Vredevoe; E F Hays
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

9.  Evidence for a blood-thymus barrier using electron-opaque tracers.

Authors:  E Raviola; M J Karnovsky
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

10.  Anatomical distribution of T and B lymphocytes in the rat. Development of lymphocyte-specific antisera.

Authors:  I Goldschneider; D D McGregor
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.